Anavex Life Sciences Corp (AVXL)

[Talon38]

As the alternative to the slow climb through the upcoming trials, the buyout is an ever present possibility. The Avexis buyout by Norvartis for $8.7B in May has been discussed before. Alexis was a small biotech with a promising drug AVXS 101 in clinical trial for SMA. Although AVXS 101 is very promising it faces Biogen's drug for SMA, Spinraza, which is already in the market. Apparently, Novartis was sold on Alexis' gene therapy MOA and paid well over the expected price at $218/share. There could be someone equally eager to get the Sigma R-1 platform, especially if the is promising news this year or next from Australia and/or Spain. That could yield the potential reward financially and from a humanitarian standpoint we are looking for. Sure adds excitement to the wait!

By the way AVXS 101 is a competitor with us in the search for an effective treatment for Rett Syndrome.

----

https://www.barrons.com/articles/avexis-sale-an-8-7-billion-endorsement-for-gene-therapy-1523664000